✓ Clinically Reviewed & Verified
Semalog 0.25mg Semaglutide Injection Pen (Starter Dose) - 1 Pre-filled Pen
Starting a new metabolic therapy for Type 2 diabetes or weight management requires a careful, stepwise approach to minimize gastrointestinal discomfort. Semalog 0.25mg is the clinical starter dose for semaglutide therapy. By acting as a GLP-1 receptor agonist, it begins the process of normalizing insulin response and curbing severe appetite cravings, allowing patients in East Africa to begin their journey toward sustainable metabolic health safely.
How to Use / Operate
Administer one 0.25mg subcutaneous injection once weekly for the first four weeks, on the same day each week. Inject into the abdomen, thigh, or upper arm. This is a starter dose intended to build tolerance; your doctor will typically increase the dose after four weeks. Store unused pens in the refrigerator.
Frequently Asked Questions
What is Semalog 0.25mg used for?
It is the initial starting dose used to introduce the body to semaglutide for improving blood sugar control and assisting in weight loss.
Will this dose lower my blood sugar immediately?
The 0.25mg dose is primarily for treatment initiation and tolerance building; significant glycemic control is typically achieved at higher maintenance doses.
Important Clinical Considerations
To reduce initial nausea, eat smaller meals and avoid high-fat foods. This medication is contraindicated in patients with a history of medullary thyroid carcinoma (MTC). Always follow your prescribing physician's titration schedule.
| Key Detail |
Value / Specification |
| Active Ingredient |
Semaglutide 0.25mg per dose |
| Therapeutic Class |
GLP-1 Receptor Agonist |
| Packaging |
1 Pre-filled Pen (Multi-dose) |
Medical Disclaimer: This information is for educational purposes only. Always consult a qualified healthcare professional before starting any new medication or using a medical device. AfyaDepo only sources authentic, verified products.
